The Prevalence and Pathobiology of Nonalcoholic Fatty Liver Disease in Patients of Different Races or Ethnicities

Clinics in Liver Disease

Volumn 20, Issue 2, 2016, Pages 215-224

  Kalia, Harmit S ^a   Gaglio, Paul J ^b  

^a MARION BESSIN LIVER RESEARCH CENTER   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Ethnicity; NAFLD; PNPLA; Race

Indexed keywords

INSULIN; LIPID; LIVER ENZYME; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ADIPONUTRIN, HUMAN; MEMBRANE PROTEIN; TRIACYLGLYCEROL LIPASE;

AFRICAN AMERICAN; BODY MASS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; ECHOGRAPHY; ETHNICITY; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEPATOGRAPHY; HISPANIC; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LABORATORY TEST; LIPID METABOLISM; LIVER BIOPSY; LIVER HISTOLOGY; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PATHOLOGY; PATHOPHYSIOLOGY; PREVALENCE; RACE DIFFERENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; CAUCASIAN; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; LIPASE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, GENETIC; PREVALENCE; UNITED STATES;

EID: 84958225659     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2015.10.005     Document Type: Review

References (34)

1. Brancati F.L., Kao W.H., Folsom A.R., et al. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000, 283:2253-2259.
2. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
3. Crespo C.J., Loria C.M., Burt V.L. Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey. Public Health Rep 1996, 111(Suppl 2):7-10.
4. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
5. Centers for Disease Control and Prevention (CDC) Vital signs: state-specific obesity prevalence among adults United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(30):951-955.
6. Hausmann L.R., Ren D., Sevick M.A. Racial differences in diabetes-related psychosocial factors and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence 2010, 4:291-299.
7. Kirk J.K., D'Agostino R.B., Bell R.A., et al. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care 2006, 29(9):2130-2136.
8. Karlamangla A.S., Merkin S.S., Crimmins E.M., et al. Socioeconomic and ethnic disparities in cardiovascular risk in the United States, 2001-2006. Ann Epidemiol 2010, 20(8):617-628.
9. Walker S.E., Gurka M.J., Oliver M.N., et al. Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutr Metab Cardiovasc Dis 2012, 22:141-148.
10. Louthan M.V., Theriot J.A., Zimmerman E., et al. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 2005, 41:426-429.
11. Quiros-Tejeira R.E., Rivera C.A., Ziba T.T., et al. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr 2007, 44:228-236.
12. Riquelme A., Arrese M., Soza A., et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 2009, 29:82-88.
13. Weston S.R., Leyden W., Murphy R., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005, 41(2):372-379.
14. Browning J.D., Szczepaniak L.S., Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
15. Wagenknecht L.E., Scherzinger A.L., Stamm E.R., et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity 2009, 17:1240-1246.
16. Pan J.J., Fisher-Hoch S.P., Chen C., et al. Burden of nonalcoholic fatty liver disease and advanced fibrosis in a Texas Hispanic community cohort. World J Hepatol 2015, 18:1586-1594.
17. Solga S.F., Clark J.M., Alkhuraishi A.R., et al. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients. Surg Obes Relat Dis 2005, 1(1):6-11.
18. Mohanty S.R., Troy T.N., Huo D., et al. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol 2009, 50:797-804.
19. Kallwitz E.R., Guzman G., TenCate V., et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol 2009, 104:64-69.
20. Bambha K., Belt P., Abraham M., et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012, 55:769-780.
21. Kallwitz E.R., Daviglus M.L., Allison M.A., et al. Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage. Clin Gastroenterol Hepatol 2015, 13(3):569-576.
22. Chang Y., Ryu S., Sung E., et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 2009, 58(10):1419-1425.
23. Bahrami H., Daryani N.E., Mirmomen S., et al. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC Gastroenterol 2003, 3:27-33.
24. Wong V.W., Hui A.Y., Tsang S.W., et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006, 4(9):1154-1161.
25. Alazawi W., Mathur R., Abeysekera K., et al. Ethnicity and the diagnosis gap in liver disease: a population-based study. Br J Gen Pract 2014, 64:694-702.
26. Guerrero R., Vega G.L., Grundy S.M., et al. Ethnic differences in hepatic steatosis: an insulin resistance paradox?. Hepatology 2009, 49(3):791-801.
27. Sumner A.E., Micklesfield L.K., Ricks M., et al. Waist circumference, BMI, and visceral adipose tissue in white women and women of African descent. Obesity 2010, 19:671-674.
28. Carroll J.F., Chiapa A.L., Rodriquez M., et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity 2008, 16(3):600-607.
29. Qureshi K., Abrams G.A. Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2007, 13(26):3540-3553.
30. Wagenknecht L.E., Palmer N.D., Bowden D.W., et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011, 31(3):412-416.
31. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40(12):1461-1465.
32. Valenti L., Alisi A., Galmozzi E., et al. I148M patatin-like phospholipase domain- containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010, 52(4):1274-1280.
33. Sookoian S., Pirola C.J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011, 53(6):1883-1894.
34. Bhatt S.P., Nigam P., Misra A., et al. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease. Metab Syndr Relat Disord 2013, 11:329.